Novo pens $285M biobucks deal to use Ascendis' tech to create monthly GLP-1 agonist 0 04.11.2024 16:44 Fiercebiotech.com Novo pens $285M biobucks deal to use Ascendis' tech to create monthly GLP-1 agonist esagonowsky Mon, 11/04/2024 - 08:44
